🚀 VC round data is live in beta, check it out!
Chandan Healthcare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Chandan Healthcare and similar public comparables like Gentian Diagnostics, Aiforia, Klea, Bioporto and more.
Chandan Healthcare Overview
About Chandan Healthcare
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
Founded
2003
HQ
Employees
1.2K
Website
Financials (FY)
EV
$74M
Chandan Healthcare Financials
Chandan Healthcare reported last fiscal year revenue of $25M and EBITDA of $5M.
In the same fiscal year, Chandan Healthcare generated $13M in gross profit, $5M in EBITDA, and $2M in net income.
Chandan Healthcare P&L
In the most recent fiscal year, Chandan Healthcare reported revenue of $25M and EBITDA of $5M.
Chandan Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $25M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 53% | XXX | XXX | XXX |
| EBITDA | — | XXX | $5M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 15% | XXX | XXX | XXX |
| Net Profit | — | XXX | $2M | XXX | XXX | XXX |
| Net Margin | — | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Chandan Healthcare Stock Performance
Chandan Healthcare has current market cap of $68M, and enterprise value of $74M.
Market Cap Evolution
Chandan Healthcare's stock price is $2.80.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $74M | $68M | 0.5% | XXX | XXX | XXX | $0.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChandan Healthcare Valuation Multiples
Chandan Healthcare trades at 3.0x EV/Revenue multiple, and 16.0x EV/EBITDA.
Chandan Healthcare Financial Valuation Multiples
As of April 20, 2026, Chandan Healthcare has market cap of $68M and EV of $74M.
Equity research analysts estimate Chandan Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chandan Healthcare has a P/E ratio of 28.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $68M | XXX | $68M | XXX | XXX | XXX |
| EV (current) | $74M | XXX | $74M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 16.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 19.8x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.6x | XXX | XXX | XXX |
| P/E | — | XXX | 28.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (10.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Chandan Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Chandan Healthcare Margins & Growth Rates
Chandan Healthcare's revenue in the last fiscal year grew by 6%.
Chandan Healthcare's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Chandan Healthcare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 10% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Chandan Healthcare Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Chandan Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Gentian Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Aiforia | XXX | XXX | XXX | XXX | XXX | XXX |
| Klea | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioporto | XXX | XXX | XXX | XXX | XXX | XXX |
| FluoGuide | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chandan Healthcare M&A Activity
Chandan Healthcare acquired XXX companies to date.
Last acquisition by Chandan Healthcare was on XXXXXXXX, XXXXX. Chandan Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Chandan Healthcare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChandan Healthcare Investment Activity
Chandan Healthcare invested in XXX companies to date.
Chandan Healthcare made its latest investment on XXXXXXXX, XXXXX. Chandan Healthcare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Chandan Healthcare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Chandan Healthcare
| When was Chandan Healthcare founded? | Chandan Healthcare was founded in 2003. |
| Where is Chandan Healthcare headquartered? | Chandan Healthcare is headquartered in India. |
| How many employees does Chandan Healthcare have? | As of today, Chandan Healthcare has over 1K employees. |
| Is Chandan Healthcare publicly listed? | Yes, Chandan Healthcare is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Chandan Healthcare? | Chandan Healthcare trades under CHANDAN ticker. |
| When did Chandan Healthcare go public? | Chandan Healthcare went public in 2025. |
| Who are competitors of Chandan Healthcare? | Chandan Healthcare main competitors are Gentian Diagnostics, Aiforia, Klea, Bioporto. |
| What is the current market cap of Chandan Healthcare? | Chandan Healthcare's current market cap is $68M. |
| What is the current revenue of Chandan Healthcare? | Chandan Healthcare's last fiscal year revenue is $25M. |
| What is the current EV/Revenue multiple of Chandan Healthcare? | Current revenue multiple of Chandan Healthcare is 3.0x. |
| Is Chandan Healthcare profitable? | No, Chandan Healthcare is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.